148 related articles for article (PubMed ID: 2576924)
1. Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitro.
Lengyel AM; Grossman A; Rees LH; Besser GM
Braz J Med Biol Res; 1989; 22(10):1311-6. PubMed ID: 2576924
[TBL] [Abstract][Full Text] [Related]
2. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
Westendorf JM; Schonbrunn A
Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.
Epelbaum J; Tapia-Arancibia L; Besson J; Rotsztejn WH; Kordon C
Eur J Pharmacol; 1979 Oct; 58(4):493-5. PubMed ID: 510382
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucagon, Neurotensin, and vasoactive intestinal polypeptide on somatostatin release from perifused rat hypothalamus.
Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
Endocrinology; 1982 Jun; 110(6):2113-7. PubMed ID: 6122561
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment.
Poplawski MM; Boyadjieva N; Sarkar DK
Alcohol Clin Exp Res; 2005 Apr; 29(4):648-55. PubMed ID: 15834231
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of the stimulant effect of 2 neuropeptides (thyroliberin (TRH) and vasoactive intestinal peptide (VIP)) on the secretion of the growth hormone in the rat].
Durand D; Bluet-Pajot MT; Mounier F; Leonard JF; Pressac M
Reprod Nutr Dev (1980); 1987; 27(2B):481-9. PubMed ID: 3114836
[TBL] [Abstract][Full Text] [Related]
9. Endogenous vasoactive intestinal peptide (VIP) regulates somatostatin secretion by cultured fetal rat cerebral cortical and hypothalamic cells.
De los Frailes MT; Sanchez Franco F; Lorenzo MJ; Tolón RM; Lara JI; Cacicedo L
Regul Pept; 1991 Jul; 34(3):261-74. PubMed ID: 1681571
[TBL] [Abstract][Full Text] [Related]
10. Effect of vasoactive intestinal peptide on the release of growth hormone in perifused pituitary and hypothalamus of the goat.
Ogwuegbu SO; Hashizume T; Kanematsu S
Domest Anim Endocrinol; 1991 Jan; 8(1):29-35. PubMed ID: 2013223
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide induces a transient release of growth hormone in the rat.
Bluet-Pajot MT; Mounier F; Leonard JF; Kordon C; Durand D
Peptides; 1987; 8(1):35-8. PubMed ID: 3575152
[TBL] [Abstract][Full Text] [Related]
13. Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro.
Lengyel AM; Grossman A; Bouloux PM; Rees LH; Besser GM
J Endocrinol; 1985 Sep; 106(3):317-22. PubMed ID: 2864381
[TBL] [Abstract][Full Text] [Related]
14. Effect of vasoactive intestinal peptide, peptide histidine isoleucine and growth hormone-releasing factor-40 on bombesin-like immunoreactivity, somatostatin and gastrin release from the perfused rat stomach.
Schusdziarra V; Schmid R; Bender H; Schusdziarra M; Rivier J; Vale W; Classen M
Peptides; 1986; 7(1):127-33. PubMed ID: 2872659
[TBL] [Abstract][Full Text] [Related]
15. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues.
Chihara K; Iwasaki J; Minamitani N; Kaji H; Matsukura S; Tamaki N; Matsumoto S; Fujita T
J Clin Endocrinol Metab; 1982 Apr; 54(4):773-9. PubMed ID: 6120948
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
17. Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors.
Schmidt PT; Rickelt LF; Holst JJ
Dig Dis Sci; 1999 Jul; 44(7):1273-81. PubMed ID: 10489905
[TBL] [Abstract][Full Text] [Related]
18. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide stimulates gonadotropin-releasing hormone release from rat hypothalamus in vitro.
Ohtsuka S; Miyake A; Nishizaki T; Tasaka K; Tanizawa O
Acta Endocrinol (Copenh); 1988 Mar; 117(3):399-402. PubMed ID: 3289303
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro.
Matsushita N; Kato Y; Katakami H; Shimatsu A; Yanaihara N; Imura H
J Clin Endocrinol Metab; 1981 Dec; 53(6):1297-300. PubMed ID: 6795228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
